43-year-old Technion research dynamo Avi Schroeder is on a mission—and a “phenomenon” with four startup ventures under his belt, he works furiously and relentlessly to identify a cure for cancer from elephant protein to personalizing chemotherapy. The Yeshiva graduate even takes on a deadly shrimp plague at this bustling lab, reports Calcalist.
Although “tiny,” it is “mighty,” reports Calcalist about his Technion Israel Institute of Technology research abode. One could argue his lab represents a snapshot of the country—small but bustling with brain power, entrepreneurial energy and a seemingly genetic impulse to make progress. The lab work of Schroeder spans topics of biology, chemistry medicine, pharmaceuticals and even topics such as mechanical engineering. Part of the chemical engineering facility, researchers in this elite unit were hand selected from various departments to commit to and serve the interdisciplinary mission.
Schroeder earned his PhD in Chemical Engineering from Ben Gurion University. He was a Postdoctoral Fellow at MIT.
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).